The challenge
A German medtech scale-up had strong clinical evidence and a product that worked. What they lacked was a commercial narrative that travelled — one that could hold its own in regulatory conversations, partnership meetings, and buyer rooms across Europe. Their science was credible. The way they were telling it wasn't landing. Two years of internal effort had failed to change that.
The approach
DSA worked with the team to rebuild their evidence narrative from the ground up — not simplifying the science, but reframing it in the commercial and clinical language that European buyers, regulators, and partners actually respond to. We developed a full science communication toolkit: positioning documents, meeting materials, and a core narrative the team could use consistently and independently across every conversation.
The outcome
Within 6 months the company had 2 distribution agreements signed, representing over €5M in combined deal value. Partners engaged where they had previously disengaged. What had taken two years to attempt internally was achieved in two quarters with the right narrative in place.
DSA helped us translate our science into a market story that European buyers actually responded to. Within 6 months we had 2 distribution agreements signed, representing over €5M in combined deal value — after two years of getting nowhere alone.
Thomas M.
The challenge
A German medtech scale-up had strong clinical evidence and a product that worked. What they lacked was a commercial narrative that travelled — one that could hold its own in regulatory conversations, partnership meetings, and buyer rooms across Europe. Their science was credible. The way they were telling it wasn't landing. Two years of internal effort had failed to change that.
The approach
DSA worked with the team to rebuild their evidence narrative from the ground up — not simplifying the science, but reframing it in the commercial and clinical language that European buyers, regulators, and partners actually respond to. We developed a full science communication toolkit: positioning documents, meeting materials, and a core narrative the team could use consistently and independently across every conversation.
The outcome
Within 6 months the company had 2 distribution agreements signed, representing over €5M in combined deal value. Partners engaged where they had previously disengaged. What had taken two years to attempt internally was achieved in two quarters with the right narrative in place.
DSA helped us translate our science into a market story that European buyers actually responded to. Within 6 months we had 2 distribution agreements signed, representing over €5M in combined deal value — after two years of getting nowhere alone.
Thomas M.